血交换改善了急性肝衰竭的存活率 - - 一个更新的系统性审查和分析,重点在于在单个病因内进行比较
Kausala Sithamparapillai1, Uday Zachariah2, C E Eapen2
1Department of Physiology, University of Jaffna, Jaffna, Sri Lanka.
概括
与标准治疗相比,治疗性血交换 (PLEX) 显著降低了急性肝衰竭 (ALF) 患者的死亡率. 这种生存益处在单一病因的ALF病例中尤为明显,PLEX证明了有利的安全性.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 关键护理医学 关键护理医学
- 移植 移植 移植 移植
背景情况:
- 治疗性血交换 (PLEX) 越来越多地用于急性肝衰竭 (ALF),作为独立治疗或通往肝移植的桥梁.
- 在ALF患者的预后和PLEX疗效可以根据潜在的病因学显著变化.
- 这次系统性审查和元分析的重点是评估PLEX在单一病因的ALF病例中的有效性.
研究的目的:
- 系统地审查和分析PLEX在治疗ALF中的疗效.
- 具体评估PLEX对单一病因ALF死亡率和不良事件的影响.
- 为了将PLEX与ALF患者的标准医学治疗 (SMT) 进行比较.
主要方法:
- 进行了系统的文献搜索,以确定在所有年龄组的ALF患者中比较PLEX和SMT的研究.
- 该协议已在PROSPERO (CRD42023442383) 登记.
- 用Mantle-Haenszel方法在随机效应模型中计算了死亡率 (≤60和90天) 和不良事件的组合风险比率.
主要成果:
- 八项研究 (284名PLEX组患者) 表明,与SMT相比,PLEX显著降低了≤60天 (RR 0.64) 和90天 (RR 0.67) 的死亡率.
- 亚组分析显示,无论PLEX体积如何,对生存都有好处.
- 三项研究 (110名患者) 关注单一病因的ALF (威尔逊病,动物杀伤性肝毒性,孕期急性脂肪肝) 表明,PLEX (RR 0.53) 更明显地减少了≤90天的死亡率.
- 没有报告PLEX相关的重大副作用.
结论:
- PLEX是一种安全有效的ALF治疗方法,与SMT相比,它可以改善存活率,而不依赖于交换量.
- PLEX的生存优势在单一病因的ALF患者中尤为显著.
- 对于精选的ALF患者来说,PLEX可以被认为是一个有价值的治疗选择.
相关概念视频
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
358
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
358
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
1.1K
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
1.1K
01:25Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
377
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
377
01:28Kidney Transplant I: Introduction
827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827